Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?Can grapefruit juice decrease lipitor's benefits?When did risperdal constas patent expire published article?Pramlintide acetate price?When will generic fiasap insulin be available?
See the DrugPatentWatch profile for Guselkumab
Guselkumab is marketed under the brand Tremfya. The drug is made by Janssen Biotech (a unit of Johnson & Johnson), so the parent company is Johnson & Johnson. [1]
Tremfya is owned and commercialized by Janssen Pharmaceuticals, which is part of Johnson & Johnson. [1]
Guselkumab is the international nonproprietary name for the active ingredient in Tremfya; the ownership and manufacturer relationships are tied to the Janssen/Johnson & Johnson organization. [1]
[1] https://www.janssen.com/janssen-products/tremfya
Other Questions About Guselkumab :